WuXi Biologics Launches WuXia ADCC PLUS™ for the Deve

WuXi Biologics Launches WuXia ADCC PLUS™ for the Development and Manufacturing of Afucosylated Antibodies that Elicit Enhanced ADCC Effect

WuXi Biologics Launches WuXia ADCC PLUS™ for the Development and Manufacturing of Afucosylated Antibodies that Elicit Enhanced ADCC Effect

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Germany , United States , Shanghai , China , Wuxi , Jiangsu , Ireland , Singapore , Chris Chen , Contract Research , Cell Line Development Platform , Manufacturing Organization , Wuxi Biologic , Wuxi Biologics , Cell Line Development ,